Chemo Drugs

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/9

encourage image

There's no tags or description

Looks like no tags are added yet.

10 Terms

1
New cards

Alkylating Agents

MoA: Cross-link DNA strands, inhibiting DNA + protein synthesis.

Cyclophosphamide and Ifosfamide

Concerns: hemorrhagic cystitis (due to acrolein)

Monitor: hematuria and dysuria

Prevention: Adequate hydration and adding Mesna with all ifosfamide doses and high cyclophosphamide doses (> 1 g/m2).


Busulfan

Concerns: pulmonary toxicity


Carmustine

Concerns: neurotoxicity (like seizures) and pulmonary toxicity


2
New cards

Platinum-Based Compounds

MoA: Cross-link DNA to interfere with DNA synthesis and replication.

Cisplatin

Concerns:

  • Hypersensitivity rxns so monitor for signs and sx of anaphylaxis.

  • Nephrotoxicity

    • Prevention: Adequate hydration, adding amifostine, and limiting dose per cycle to < 100 mg/m2.

    • Monitor renal function.

  • Ototoxicity so monitor signs and sx of hearing loss or tinnitus and perform an audiogram at baseline.

  • Peripheral neuropathy so monitor fos signs and sx of extremity numbness, paresthesia, and/or pain.


Oxaliplatin

Concern: Acute sensory neuropathy exacerbated by cold so avoid cold exposures and monitor for abnormal sensations in the hands, feet, throat, etc.


3
New cards

Anthracyclines

MoA: Inhibits topoisomerase II.

Doxorubicin (-rubi- = red body fluids )

Concern: cardiotoxicity so monitor LVEF before and after tx

Prevention: Limit total lifetime cumulative dose to 450-550 mg/m2 and admin dexraxozane when cumulative dose in > 300 mg/m2. Must stop drug once it meets threshold.

Monitor: cumulative dose = dose in mg/m2/cycle x total number of cycles


Mitoxantrone (blue discoloration)

4
New cards

Topoisomerase I Inhibitors

MoA: Blocks the coiling and uncoiling of the double-stranded DNA helix during the S-phase.

Irinotecan

Concerns: acute diarrhea (during or immediately after) + cholinergic sx and also, delayed diarrhea (> 24 hrs after infusion)

Prevention: atropine (anticholinergic) for acute diarrhea

Treatment: loperamide for delayed diarrhea

5
New cards

Topoisomerase II Inhibitors

MoA: Blocks the coiling and uncoiling of double-stranded DNA during the G2 cycle.

Etoposide

Concern: infusion rate-relation hypotension so infuse over at least 30-60 minutes.

6
New cards

Vinca Alkaloids

MoA: Inhibit microtubule formation during the M phase.

Vincristine

Concerns:

  • Peripheral neuropathy so monitor for extremity numbness, paresthesia, and pains.

    • Prevention: limit single dose to 2 mg

  • Autonomic neuropathy (e.g., constipation)

  • Paralysis and death if given intrathecally.

    • Prevention: prepare in small IV bad (like piggybacks) that canโ€™t be use for intrathecal admin.


7
New cards

Taxanes

MoA: Inhibits the depolymerization of tubulin during the M phase.

Paclitaxel

Note: Use non-PVC bag + tubing and a 0.22 micron filter.

Concerns:

  • Peripheral neuropathy

  • Hypersensitivity rxns

    • Prevention: pre-medicare with systemic steroid, diphenhydramine, and H2RA


Docetaxel

Concern: fluid retention


8
New cards

Pyrimidine Analog Antimetabolites

MoA: Inhibit pyrimidine DNA synthesis during S phase.

Fluorouracil and Capecitabine

Concerns:

  • Hand-foot syndrome (palmar plantar erythrodysesthesia) so monitor for painful erythema and skin peeling.

    • Management: use lukewarm water/cold compresses, apply emollients, limit activities that increase friction and pressure to hands and feets, etc.

  • Diarrhea

  • Mucositis

    • Prevention: good oral hygiene, ice chips, and frequent rinsing with sodium bicarbonate or NaCl solutions

    • Treatment: viscous lidocaine 2% magic mouthwash and thrush treatment (nystatin oral susp or clotrimazole troches) if indicated.

  • DPD deficiency increases risk of severe toxicity

    • Treatment: use uridine triacetate within 96 hrs for overdose or early-onset toxicity

  • Drug interaction with warfarin (can increase INR).

Note: Leucovorin or levoleucovorin is admin with 5FU to increase efficacy.


9
New cards

Folate Antimetabolites

MoA: Interferes with enzyme incolved in the folic acid cycle, blocking purine and pyrimidine biosynthesis during the S phase.

Methotrexate

Concerns:

  • Nephrotoxicity with high doses > 500 mg/m2

    • Prevention: use leucovorin or levoleucovorin, hydrate with IV sodium bicarbonate to alkalinize urine, and avoid NSAIDs + salicylates.

    • Treatment: Glucarpidase

  • Gastrointestinal toxicity (e.g., diarrhea, mucositis)

*Folic acid is not effective for high dose dose.


10
New cards

Miscellaneous Chemo Agents

  • Arsenic trioxide

    • QT prolongation

  • Bleomycin

    • Pulmonary toxicity so limit cumulative dose to 400 units.

    • Hypersensitivity rxns

  • Bortezomib and Carfilzomib

    • Herpes reactivation (zoster and simplex) so tx with acyclovir or valacyclovir.

  • Lenalidomide, Pomalidomide, and Thalidomide

    • Severe birth defects so at baseline, it requires 2 (-) tests before starting treatment.

    • Thrombosis (DVT/PE)

  • Pegaspargase

    • Hypersensitivity rxns